Citrin Foundation’s Post

Korea Medical Devices Industry Association(KMDIA) International Affairs Committee Chairman Kit Tang and Asia Pacific Medical Technology Association (APACMed) CEO Harjit Gill met last month in Singapore to celebrate APACMed’s 10th anniversary. Based on the long-standing partnership between two associations, KMDIA and APACMed agreed to develop a strategic cooperation plan to jointly promote education and training, industry support for regulatory reliance, and regulation improvement by co-developing position papers. KMDIA Vice-Chair Kit Tang said, “As Korea is a leading regulatory country in the Asia-Pacific region, other Asia-Pacific countries will also show great interest in concluding regulatory reliance agreements with Korea,” and added, “We will actively refer to APACMed’s case study and advice on concluding agreements between Thailand and Singapore when promoting regulatory reliance agreements between Korea and Asia-Pacific countries in the future.” #medtech #partnerships #digitalhealth #innovation #advocacy https://lnkd.in/ghrkjcJ8

Planning to attend DIA-San Diego? Let's schedule a time to meet and explore potential synergies for Japan and Asian Market. Together, we can make clinical trials more accessible, efficient, and patient-friendly in Japan. ⛩⛩ #DIA2024 #ClinicalTrialsInnovation #PatientFirst #HomeBasedTrials #HealthcareCollaborationInJapan #RemoteTrialinJapan #ClinicalTrialinAsia

Interesting read

"VAT-Free Medical Services in Indonesia: How Does It Compare in ASEAN?" The policy of exempting VAT on medical health services in Indonesia is a crucial step toward ensuring accessibility and affordability of healthcare for all. This initiative aligns with practices in other ASEAN countries, albeit with variations based on each nation's fiscal and healthcare priorities. By examining these comparisons, Indonesia can better evaluate the impact of this policy on the effectiveness and efficiency of healthcare services. Affordable healthcare is an investment in collective well-being. https://lnkd.in/gTmRdsuj

JAPAN CLINICAL TRIALS Why choose #Japan for conducting clinical trials? Explore its state-of-the-art medical facilities, rigorous regulatory standards, world-class scientific expertise, and captivating cultural heritage. #ClinicalTrials #ResearchInJapan #pmda Click on the link below to discover why you should choose Japan for your clinical trials and learn about the regulatory process for conducting clinical trials in Japan. 👉 Contact @Credevo for conducting clinical trials in Japan https://lnkd.in/gZPRdsFt

JAPAN CLINICAL TRIALS Why choose #Japan for conducting clinical trials? Explore its state-of-the-art medical facilities, rigorous regulatory standards, world-class scientific expertise, and captivating cultural heritage. #ClinicalTrials #ResearchInJapan #pmda Click on the link below to discover why you should choose Japan for your clinical trials and learn about the regulatory process for conducting clinical trials in Japan. 👉 Contact @Credevo for conducting clinical trials in Japan https://lnkd.in/g-Pq9tt7

Roy Medical Assistance Pvt. Ltd. Announce International #MedicalAssistance and #TPA Service Offering in #Japan Sumit Gaurav, Founder and CEO Roy Medical Assistance Pvt. Ltd. comments, “In Japan we are in the initial stage to develop our direct billing agreement with providers in major cities. We are constantly working in the region to develop more hospital network access across Japan. As we know, medical costs in Japan, are higher compared to other Asian countries, so we are developing more hospital relationships in our network and cost containment process, with our preferred provider network.” Read the full story on iPMI Global: https://lnkd.in/eiTTRWJG

The ISPOR Pharmacoeconomic Guidelines Around the World is a comprehensive collection of available pharmacoeconomic/health economic (PE) guidelines from individual countries, either published PE recommendations, PE guidelines, or submission guidelines. This tool, which offers a table of 33 key features for each country's/region's guidelines, is one of the most widely used that ISPOR offers to the public. Visit ISPOR’s PE Guidelines Around the World: https://ow.ly/tFQy50RSPmU. For the first time, pages are now available for India and South Korea! Click here to view India: https://ow.ly/911g50RSPmS and South Korea: https://ow.ly/o6aQ50RSPmR. Additionally, the webpage for Malaysia was just updated to reflect the new Guidelines on Submission of Dossier for Listing into the Ministry of Health Medicines Formulary, 2024. Check it out here: https://ow.ly/kVJb50RSPmT. A huge thanks to our volunteer reviewers who contributed the summary tables. #HEOR #HTA

Ceibo Health Consulting highly supports this initiative as a great resource to have a landscape of Pharmacoeconomic Recommendations, Guidelines, and Submission guidance around the world as well. The guidelines enhance the robustness of a study and lower uncertainty in terms of methodology. Guidelines are per se dynamic and as such, are periodically revised by ISPOR together with volunteers. #HEOR #pharmacoeconomics #marketaccess #latam